Fraser MacDonald
Fortuna: 36 108 $ al 31/05/2026
Fortuna: 36 108 $ al 31/05/2026
Fraser MacDonald is currently an Independent Director at Pharmala Biotech Holdings, Inc. since 2021 and a Director at Pharmala Biotech, Inc. Education history includes an undergraduate degree from Queen's University and a graduate degree from Bond University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/04/2026 | 306.000 ( 0,28 % ) | 36 108 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Director/Miembro de la Junta | 21/03/2021 |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bond University
Bond University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmAla Biotech Holdings, Inc.
PharmAla Biotech Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and sells pharmaceutical ingredients | Health Technology |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.